Literature DB >> 17153817

Subjective and objective measures of quality of life have different predictors for people with schizophrenia.

Masahito Tomotake1, Yasuhiro Kaneda, Jun-Ichi Iga, Sawako Kinouchi, Sumiko Tayoshi, Ikuyo Motoki, Satsuki Sumitani, Ken Yamauchi, Takahide Taniguchi, Yasuhito Ishimoto, Shu-Ichi Ueno, Tetsuro Ohmori.   

Abstract

This study investigated the relationship between subjective and objective quality of life and assessed predictors in people with schizophrenia. The study population consisted of 99 stabilized outpatients with schizophrenia (DSM-IV) who had been regularly receiving outpatient treatment at the Department of Psychiatry, The Tokushima University Hospital. Subjective and objective quality of life were estimated using the Schizophrenia Quality of Life Scale and the Quality of Life Scale, respectively. Psychiatric symptoms were also measured with the Brief Psychiatric Rating Scale and the Calgary Depression Scale for Schizophrenia. Scores on the Schizophrenia Quality of Life Scale Motivation and Energy scales significantly correlated with the Quality of Life Scale total scores -.40 (p <.001), and with the scores on Interpersonal Relations subscale -.42 (p <.001), Instrumental Role subscale -.28 (p = .005), Intrapsychic Foundations subscale -.39 (p<.001), and Common Objects and Activities subscale -.25 (p =.014). The Schizophrenia Quality of Life Scale Psychosocial scale significantly correlated with only the Quality of Life Scale total score -.20 (p =.05), and there was no significant correlation between the scores on the Schizophrenia Quality of Life Scale Symptoms and Side-effects scales and the Quality of Life Scale. Stepwise regression analyses showed that the Calgary Depression Scale for Schizophrenia score was the most important predictor of each scale of the Schizophrenia Quality of Life Scale, and the Brief Psychiatric Rating Scale Negative Symptoms score was the most important predictor of the Quality of Life Scale total score and each subscale. These results suggest that subjective and objective quality of life have different predictors and should be considered as separate and complementary outcome variables.

Entities:  

Mesh:

Year:  2006        PMID: 17153817     DOI: 10.2466/pr0.99.2.477-487

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  12 in total

Review 1.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

2.  Association between depression in chronic phase and future clinical outcome of patients with schizophrenia.

Authors:  Yuto Yamada; Yusuke Yamauchi; Shinji Sakamoto; Masaki Fujiwara; Yuko Okahisa; Soshi Takao; Manabu Takaki; Norihito Yamada
Journal:  Psychopharmacology (Berl)       Date:  2022-02-21       Impact factor: 4.530

3.  Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.

Authors:  Adesanmi Akinsulore; Olutayo O Aloba; B M Mapayi; I O Oloniniyi; F O Fatoye; R O A Makanjuola
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

4.  Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.

Authors:  Koichiro Fujimaki; Terumichi Takahashi; Shigeru Morinobu
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

5.  Validity of subjective versus objective quality of life assessment in people with schizophrenia.

Authors:  Karen P Hayhurst; Jennifer A Massie; Graham Dunn; Shôn W Lewis; Richard J Drake
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

6.  Cultural adaptation and validity of the Malay version of the brief psychiatric rating scale (BPRS-M) among patients with schizophrenia in a psychiatric clinic.

Authors:  Anne Yee; Boon Seng Ng; Helenna Maria Hisham Hashim; Mahmoud Danaee; Huai Heng Loh
Journal:  BMC Psychiatry       Date:  2017-12-02       Impact factor: 3.630

7.  Relationship between social and cognitive functions in people with schizophrenia.

Authors:  Takeo Tominaga; Masahito Tomotake; Tomoya Takeda; Yoshinori Ueoka; Tsunehiko Tanaka; Shin-Ya Watanabe; Naomi Kameoka; Masahito Nakataki; Shusuke Numata; Yumiko Izaki; Satsuki Sumitani; Hiroko Kubo; Yasuhiro Kaneda; Tetsuro Ohmori
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-30       Impact factor: 2.570

8.  Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study.

Authors:  Masashi Ohta; Masahito Nakataki; Tomoya Takeda; Shusuke Numata; Takeo Tominaga; Naomi Kameoka; Hiroko Kubo; Makoto Kinoshita; Kanae Matsuura; Maki Otomo; Naoya Takeichi; Masafumi Harada; Tetsuro Ohmori
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-15       Impact factor: 2.570

9.  Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia.

Authors:  Jong-Hoon Kim; Seul Lee; Ah-Young Han; Kyungwook Kim; Jinyoung Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-07       Impact factor: 2.570

10.  Insular Gray Matter Volume and Objective Quality of Life in Schizophrenia.

Authors:  Teruhisa Uwatoko; Miho Yoshizumi; Jun Miyata; Shiho Ubukata; Hironobu Fujiwara; Ryosaku Kawada; Manabu Kubota; Akihiko Sasamoto; Genichi Sugihara; Toshihiko Aso; Shinichi Urayama; Hidenao Fukuyama; Toshiya Murai; Hidehiko Takahashi
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.